Dr. Reddys Laboratories Ltd.

Dr. Reddy’s Laboratories is currently trading at Rs. 2052.00, up by 6.05 points or 0.30% from its previous closing of Rs. 2045.95 on the BSE.

The scrip opened at Rs. 2046.00 and has touched a high and low of Rs. 2150.10 and Rs. 2030.00 respectively. So far 22,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3394.95 on 28-Oct-2016 and a 52 week low of Rs. 1901.65 on 11-Aug-2017.

Last one week high and low of the scrip stood at Rs. 2150.10 and Rs. 1990.00 respectively. The current market cap of the company is Rs. 34,020.00 crore.

The promoters holding in the company stood at 26.78%, while Institutions and Non-Institutions held 43.38% and 13.68% respectively.

Dr. Reddy’s Laboratories has launched a US marketing campaign to reintroduce back pain-reliever Doan’s, available in caplets and a new 4% lidocaine plus menthol cream formulation (the maximum strength of lidocaine available without prescription). For more than a century, Doan’s has been synonymous with back pain relief. Now, with its new lidocaine cream, Doan’s is equipped to achieve its mission with even more back pain sufferers in the years ahead.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.